The Better Bakehouse Snack Company is recalling certain lots of Donutful Chocolate Dipped Vanilla Cake Donuts because they may contain undeclared milk, an allergen not listed on the package. The Donutful chocolate dipped donuts recall affects 7.05 oz cartons carrying lot code 26078, best if used by 9/15/2026, distributed to retailers nationwide and through Amazon.com.
What Was Recalled, and Why
According to the FDA recall notice, published August 24, 2026, the affected product is:
- Product: Donutful Chocolate Dipped Vanilla Cake Donuts, 5 individually wrapped 1.41 oz (40g) pouches per 7.05 oz (200g) carton
- UPC: 3 50041 39210 3
- Lot code: 26078
- Best if used by: 9/15/2026
- Distribution: Nationwide retailers and Amazon.com; the affected donuts were manufactured and distributed in March 2026
- Reason for recall: The product may contain undeclared milk, which was not listed as an ingredient on the label
The company, The Better Bakehouse Snack Company (which sells Donutful products under its Bakeful brand), says the recall was prompted by a consumer allergic reaction. Anyone with a milk allergy or intolerance who has this lot should not eat the product.
What to Do If You Have This Product
Consumers can dispose of the affected donuts and get a refund from their point of purchase with a receipt, or return the product to their point of purchase for a refund. Questions can be directed to the company’s consumer line at 800-243-0335, Monday through Friday, 9 a.m. to 4 p.m. ET.
Is This Common?
Undeclared allergens are consistently one of the leading causes of food recalls in the United States. Milk is one of the nine major food allergens the FDA requires to be clearly listed on labels under federal allergen labeling law, alongside eggs, wheat, soy, peanuts, tree nuts, fish, shellfish, and sesame. A labeling slip-up, a shared production line, or a packaging mix-up can all trigger this type of recall, even when the product itself isn’t otherwise unsafe for most consumers.
Update Log
- August 27, 2026: Article published, following the FDA notice announced August 24, 2026.
